The hungry stomach: Physiology, disease, and drug development opportunities

Frontiers in Pharmacology

Volumn FEB, Issue , 2011, Pages

  Sanger, Gareth J ^a   Hellström, Per M ^b   Näslund, Erik ^c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UPPSALA UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Des acyl ghrelin; Ghrelin; Migrating motor complex; Motilin; Obestatin; Stomach

Indexed keywords

ANTIBIOTIC AGENT; BMS 604992; CAMICINAL; DES ACYL GHRELIN; ERYTHROMYCIN; EX 1314; GASTROINTESTINAL AGENT; GHRELIN; GHRELIN RECEPTOR; GLUCAGON LIKE PEPTIDE 1; GROWTH HORMONE; IPAMORELIN; LOPERAMIDE; MA 2029; MITEMCINAL; MOTILIN; OBESTATIN; OCTREOTIDE; OREXIN; RQ 00201894; ST 1141; TZP 102; TZP 201; ULIMORELIN; UNCLASSIFIED DRUG;

ABDOMINAL CRAMP; ABDOMINAL SURGERY; ANOREXIA NERVOSA; APPETITE; ARTICLE; BACTERIAL OVERGROWTH; DIARRHEA; DIGESTIVE FUNCTION; DRUG DOSE TITRATION; DRUG STRUCTURE; DYSPEPSIA; ENTEROPATHY; FOOD INTAKE; GASTRIC DYSMOTILITY; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL MOTILITY DISORDER; GASTROINTESTINAL TRANSIT; HORMONE RELEASE; HUMAN; HUNGER; INTESTINE INNERVATION; IRRITABLE COLON; LOW DRUG DOSE; MIGRATING MOTOR COMPLEX; NAUSEA; NONHUMAN; POSTOPERATIVE ILEUS; STOMACH EMPTYING; STOMACH PARESIS; VAGUS NERVE; VOMITING;

EID: 84865998015     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2010.00145     Document Type: Article

References (160)

1. Ang, D. C., Nicolai, H., Vos, R., Berghe, P. V., Sifrim, D., Depoortere, I., Peeters, T. L., Janssens, J., and Tack, J. E (2008a). Hunger scores correlate with the occurrence of pharmacologically induced gastric phase 3 in man. Gastroenterology 134(Suppl. 1), A-285.
2. Ang, D. C., Nicolai, H., Vos, R., Berghe, P. V., Sifrim, D., Depoortere, I., Peeters, T. L., Janssens, J., and Tack, J. F. (2008b). Gastric phase 3 is a hunger signal in the interdigestive state in man. Gastroenterology 134(Suppl. 1), A-314.
3. Argia, H., Tsukamoto, K., Chen, C., Mantyh, C., Pappas, T. N., and Takahashi, T. (2007). Endogenousacyl ghrelin is involved in mediating spontaneous phase III-like contractions of the rat stomach. Neurogastroenterol. Motil. 19, 675-680.
4. Asakawa, A., Inui, A., Kaga, T., Yuzuriha, H., Nagata, T., Ueno, N., Makino, S., Fujimiya, M., Niijima, A., Fujino, M. A., and Kasuga, M. (2001). Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 120, 337-345.
5. Ashitani, J. -I., Matsumoto, N., and Nakazato, M. (2009). Ghrelin and its therapeutic potential for cachectic patients. Peptides 30, 1951-1956.
6. Ataka, K., Inui, A., Asakawa, A., Kato, I., and Fujimiya, M. (2008). Obestatin inhibits motor activity in the antrum and duodenum in the fed state of conscious rats. Am. J. Physiol. 294, G1210-G1218.
7. Azriel-Tamir, H., Sharir, H., Schwartz, B., and Hershfinkel, M. (2004). Extracellular zinc triggers ERK-dependent activation of Na+/H+ exchange in colonocytes mediated by the zinc-sensing receptor. J. Biol. Chem. 279, 51804-51816.
8. Baccari, M. C., Bani, D., and Calamai, E (2009). Evidence for a modulatory role of orexin A on the nitrergic neu-rotransmission in the mouse gastric fundus. Regul. Pept. 154, 54-59.
9. Banks, W. A., Tschöp, M., Robinson, S. M., and Heiman, M. L. (2002). Extent and direction of ghrelin transport across the blood brain barrier is determined by its unique primary structure. J. Pharmacol. Exp. Ther. 302, 822-827.
10. Bassil, A. K., Häglund, Y., Brown, J., Rudholm, T., Hellström, P. M., Näslund, E., Lee, K., and Sanger, G. J. (2007). Little or no ability of obestatin to interact with ghrelin or modify motility in the rat gastrointestinal tract. Br. J. Pharmacol. 150, 58-64.
11. Becskei, C., Bilik, K. U., Klussmann, S., Jarosch, F., Lutz, T. A., and Riediger, T. (2008). The anti-ghrelin Spiegelmer NOX-B11-3 blocks ghrelin- but not fasting-induced neuronal activation in the hypothalamic arcuate nucleus. J. Neuroendocrinol. 20, 85-92.
12. Benson, M. J., Roberts, J. P., Wingate, D. L., Rogers, J., Deeks, J. J., Castillo, E D., and Williams, N. S. (1994). Small bowel motility following major intra-abdominal surgery: the effects of opiates and rectal cisapride. Gastroenterology 106, 924-936.
13. Boivin, M. A., Carey, M. C., and Levy, H. (2003). Erythromycin accelerates gastric emptying in a dose-response manner in healthy subjects. Pharmacotherapy 23, 5-8.
14. Bray, G. A. (2000). Afferent signals regulating food intake. Proc. Nutr. Soc. 59, 373-384.
15. Bresciani, E., Rapetti, D., Donà, F., Bulgarelli, I., Tamiazzo, L., Locatelli, V., and Torsello, A. (2006). Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat. J. Endocrinol. Invest. 29, RC16-RC18.
16. Broad, J., Mukherjee, S., Boundouki, G., Dukes, G. E., and Sanger, G. J. (2010). Different abilities of [Nle13]-motilin and the motilin receptor agonist GSK962040 to facilitate cholinergic and nitrergic activity in human isolated stomach. Neurogastroenterol. Motil. 22, 84.
17. Broglio, F., Gianotti, L., Destefanis, S., Fassino, S., Abbate Daga, G., Mondelli, V., Lanfranco, F., Gottero, C., Gauna, C., Hofland, L., Van der Lely, A. J., and Ghigo, E. (2004). The endocrine response to acute ghrelin administration is blunted in patients with ano-rexianervosa, a ghrelin hypersecretory state. Clin. Endocrinol. 60, 592-599.
18. Bülbül, M., Tan, R., Gemici, B., Ozdem, S., Ustünel, I., Acar, N., and Izgüt-Uysal, V. N. (2010). Endogenous orexin-A modulates gastric motility by peripheral mechanisms in rats. Peptides 31, 1099-1108.
19. Camilleri, M., Papathanasopoulos, A., and Odunsi, S. T. (2009). Action and therapeutic pathways of ghrelin for gastrointestinal disorders. Nat. Rev. Gastroenterol. Hepatol. 6, 343-352.
20. Carreras, C. W., Claypool, M., Santi, D. V., Schuukes, J., Peeters, T. L., and Johnson, R. G. (2004). Tachyphylaxis assays for motilin agonist drug development. Gastroenterology 126, A276.
21. Chapman, M., Fraser, R., Vozzo, R., Bryant, L., Tam, W., Nguyen, N., Zacharakis, B., Butler, R., Daavidson, G., and Horowitz, M. (2005). Antro-pyloro-duodenal motor responses to gastric and duodenal nutrient in critically ill patients. Gut 54, 1384-1390.
22. Charoenthongtrakul, S., Giuliana, D., Longo, K. A., Govek, E. K., Nolan, A., Gagne, S., Morgan, K., Hixon, J., Flynn, N., Murphy, B. J., Hernandez, A. S., Li, J., Tino, J. A., Gordon, D. A., DiStefano, P. S., and Gedes, B. J. (2009). Enhanced gastrointestinal motility with orally active ghrelin receptor agonists. J. Pharmacol. Exp. Ther. 329, 1178-1186.
23. Chen, C. -Y., Asakawa, A., Fujimya, M., Lee, S. -D., and Inui, A. (2009). Ghrelin gene products and the regulation of food intake and gut motility. Pharmacol. Rev. 61, 430-481.
24. Chen, C. -Y., Inui, A., Asakawa, A., Fujino, K., Kato, I., Chen, C. C., Ueno, N., and Fujimiya, M. (2005). Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats. Gastroenterology 129, 8-25.
25. Chung, S. A., Greenberg, G. R., and Diamant, N. E. (1995). Vagal control of fasting somatostatin levels. Neurogastroenterol. Motil. 7, 73-78.
26. Cline, M. A., Prall, B. C., Rogers, J. O., and Tachibana, T. (2009). Satiety induced by central stresscopin is mediated by corticotrophin-releasing factor receptors and hypothalamic changes in chicks. Pharmacol. Biochem. Behav. 92, 663-669.
27. Corbetta, S., Peracchi, M., Cappiello, V., Lania, A., Lauri, E., Vago, L., Beck-Peccoz, P., and Spada, A. (2003). Circulating ghrelin levels in patients with pancreatic and gastrointestinal neuroendocrine tumors: identification of one pancreatic ghrelinoma. J. Clin. Endocrinol. Metab. 88, 3117-3120.
28. Coulie, B., Tack, J., Peeters, T., and Janssens, J. (1998). Involvement of two different pathways in the motor effects of erythromycin on the gastric antrum in humans. Gut 43, 395-400.
29. Cummings, D. E., Purnell, J. Q., Frayo, R. S., Schmidova, K., Wisse, B. E., and Weigle, D. S. (2001). Aprepran dial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50, 1714-1719.
30. Cuomo, R., Vandaele, P., Coulie, B., Peeters, T., Depoortere, I., Janssens, J., and Tack, J. (2006). Influence of motilin on gastric fundus tone and on meal-induced satiety in man: role of cholinergic pathways. Am. J. Gastroenterol. 101, 804-811.
31. Dass, N. B., Hill, J., Muir, A., Testa, T., Wise, A., and Sanger, G. J. (2003a). The rabbit motilin receptor: molecular characterisation and pharmacology. Br. J. Pharmacol. 140, 948-954.
32. Dass, N. B., Monunyara, M., Bassil, A. K., Hervieu, G. J., Osbourne, S., Corcoran, S., Morgan, M., and Sanger, G. J. (2003b). Growth hormone secreta-gogue receptors in the rat and human gastrointestinal tract and the effects of ghrelin. Neuroscience 120, 443-453.
33. Date, Y., Murakami, N., Toshinai, K., Matsukura, S., Niijima, A., Matsuo, H., Kangawa, K., and Nakazato, M. (2002). The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 123, 1120-1128.
34. Davenport, A. P., Bonner, T. I., Foord, S. M., Harmar, A. J., Neubig, R. R., Pin, J. -P., Spedding, M., Kojima, M., and Kangawa, K. (2005). International union of pharmacology. LVI. Ghrelin receptor nomenclature, distribution, and function. Pharmacol. Rev. 57, 541-546.
35. Davidson, H. I., Pilot, M. -A., and Thompson, H. H. (1990). Involvement of 5-hydroxytryptamine in canine intestinal motility patterns. J. Gastrointest. Motil. 2, 31-39.
36. De Smet, B., Thijs, T., Peeters, T. L., and Depoortere, I. (2007). Effect of peripheral obestatin on gastric emptying and intestinal contractility in rodents. Neurogastroenterol. Motil. 19, 211-217.
37. De Winter, B. Y., De Man, J. G., Seerden, T. C., Depoortere, I., Herman, A. G., Peeters, T. L., and Pelckmans, P. A. (2004). Effect of ghrelin and growth hormone-releasing pep tide 6 on septic ileus in mice. Neurogastroenterol. Motil. 16, 439-446.
38. Depoortere, I. (2009). Targeting the ghrelin receptor to regulate food intake. Regul. Pept. 156, 13-23.
39. Dhir, R., and Richter, J. E. (2004). Erythromycin in the short and long-term control of dyspepsia symptoms in patients with gastroparesis. J. Clin. Gastroenterol. 38, 237-242.
40. Dibaise, J. K., and Quigley, E. M. (1999). Efficacy of prolonged administration of intravenous erythromycin in an ambulatory setting as treatment of severe gastroparesis: one centre's experience. J. Clin. Gastroenterol. 28, 131-134.
41. Dukes, G. E., Barton, M., Dewit, O., Hicks, K., Vasist, L., Van Hecken, A., De Hoon, J., Verbeke, K., Young, M., Williams, P., and Alpers, D. (2009). Pharmacokinetics, safety/tolerabil-ity, and effect on gastric emptying of the oral motilin receptor agonist, GSK962040, in healthy male and female volunteers. Neurogastroenterol. Motil. 21, 84.
42. Dukes, G. E., Barton, M., Dewit, O., Stephens, K., Vasist, L., Young, M., Richards, D., Alpers, D., and Williams, P. (2010). Safety/tolerability, pharmacokinetics (PK), and effect on gastric emptying (GE) with 14-days repeat oral dosing of the motilin receptor agonist, GSK962040, in healthy male and female volunteers. Neurogastroenterol. Motil. 22, 14-15.
43. Dun, S. L., Brailoiu, G. C., Brailoiu, E., Yang, J., Chang, J. K., and Dun, N. J. (2006). Distribution and biological activity of obestatin in the rat. J. Endocrinol. 191, 481-489.
44. Edholm, T., Levin, F., Hellstrom, P. M., and Schmidt, P. T. (2004). Ghrelin stimulates motility in the small intestine of rats through intrinsic cholinergic neurons. Regul. Pept. 121, 25-30.
45. Egerød, K. L., Holst, B., Petersen, P. S., Hansen, J. B., Mulder, J., Hökfelt, T., and Schwartz, T. W. (2007). GPR39 splice variants versus antisense gene LYPD1: expression and regulation in gastrointestinal tract, endocrine pancreas, liver, and white adipose tissues. Mol. Endocrinol. 21, 1685-1698.
46. Ehrström, M., Gustafsson, T., Finn, A., Kirchgessner, A., Grybäck, P., Jacobsson, H., Hellström, P. M., and Näslund, E. (2005). Inhibitory effect of exogenous orexin A on gastric emptying, plasma leptin, and the distribution of orexin and orexin receptors in the gut and pancreas in man. J. Clin. Endocrinol. Metab. 90, 2370-2377.
47. Esler, W. P., Rudolph, J., Claus, T. H., Tang, W., Barucci, N., Brown, S. -E., Bullock, W., Daly, M., DeCarr, L., Li, Y., Milardo, L., Molstad, D., Zhu, J., Gardell, S. J., Livingston, J. N., and Sweet, L. J. (2007). Small-molecule ghrelin receptor antagonists improve glucose tolerance, suppress appetite and promote weight loss. Endocrinology 148, 5175-5185.
48. Falkén, Y., Hellström, P. M., Sanger, G. J., Dewit, O., Grybäck, P., Holst, J. J., and Näslund, E. (2010). Actions of prolonged ghrelin infusion on gastrointestinal transit and glucose homeostasis in humans. Neurogastroenterol. Motil. 22, el92-e200.
49. Feurle, G. E., Pfeiffer, A., Schmidt, T., Dominguez-Munoz, E., Malfertheiner, P., andHamscher, G. (2001). Phase III of the migrating motor complex: associated with endogenous xenin plasma peaks and induced by exogenous xenin. Neurogastroenterol. Motil. 13, 237-246.
50. Foster-Schubert, K. E., and Cummings, D. E. (2006). Emerging therapeutic strategies for obesity. Endocr. Rev. 27, 779-793.
51. Fraser, G. L., Hoveyda, H. R., Venkova, K., Johnson, A., Samia, M., Greenwood-Van Meerveld, B., and Tannenbaum, G. S. (2005). Pharmacological separation of gastrointestinal and endocrine effects of ghrelin using anovel ghrelin agonist, TZP-101. Neurogastroen terol. Motil. 17, 85.
52. Fujimiya, M., Asakawa, A., Ataka, K., Chen, C. -Y., Kato, I., and Inui, A. (2010). Ghrelin, des-acyl ghrelin, and obestatin: regulatory roles on the gastrointestinal motility. Int. J. Pept. 2010, 8.
53. Gill, R. C., Kellow, J. E., and Wingate, D. L. (1987). Gastro-oesophageal reflux and the migrating motor complex. Gut 28, 929-934.
54. Gourcerol, G., Million, M., Adelson, D. W., Wang, Y., Wang, L., Rivier, J., St-Pierre, D. H., and Taché, Y. (2006). Lack of interaction between peripheral injection of CCK and obestatin in the regulation of gastric satiety signaling in rodents, Peptides 27, 2811-2819.
55. Guerrero-Lindner, E., Arruebo, M. P., Murillo, M. D., andPlaza, M. A. (1996). Effect of motilin on, gastrointestinal myoelectricactivity in conscious rabbits. Peptides 17, 901-907.
56. Gutierrez, J. A., Solenberg, P. J., Perkins, D. R., Willency, J. A., Knierman, M. D., Jin, Z., Witcher, D. R., Luo, S., Onyia, J. E., and Hale, J. E. (2008). Ghrelin octanoylation mediated by an orphan lipid transferase. Proc. Natl. Acad. Sci. U. S. A. 105, 6320-6325.
57. Hall, K. E., Greenberg, G. R., El-Sharkawy, T. Y., and Diamant, N. E. (1984). Relationship between porcine motilin-induced migrating complex-like activity, vagal integrity and endogenous motilin release in dogs. Gastroenterology 87, 76-85.
58. He, J., Irwin, D. M., Chen, R., and Zhang, Y. (2010). Stepwise loss of motilin and its specific receptor genes in rodents. J. Mol. Endocrinol. 44, 37-44.
59. Hellström, P. M. Geliebter, A., Näslund, E., Schmidt, P. T., Yahav, E. K., Hashim, S. A., and Yeomans, M. R. (2004). Peripheral and central signals in the control of eating in normal, obese and binge-eating human subjects. Br. J. Nutr. 92(Suppl. 1), 47-57.
60. Hershfinkel, M., Silverman, W. F., and Sekler, I. (2007). The zinc sensing receptor, a link between zinc and cell signalling. Mol. Med. 13, 331-336.
61. Holst, B., Egerød, K. L., Schild, E., Vickers, S. P., Cheetham, S., Gerlach, L. -O., Storjohann, L., Stidsen, C. E., Jones, R., B-Sickinger, A. G., and Schwartz, T. W. (2007). GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology 148, 13-20.
62. Huda, M. S. B., Wilding, J. P. H., and Pinkney, J. H. (2006). Gut peptides and the regulation of appetite. Obes. Rev. 7, 163-182.
63. Husebye, E. (1999). The patterns of small bowel motility: physiology and implications in organic disease and functional disorders. Neurogastroenterol. Motil. 11, 141-161.
64. Inatomi, N., Sato, F., Marui, S., Itoh, Z., and Omura, S. (1996). Vagus-dependent and vagus-independent mechanisms of action of the erythromycin derivative EM574 and motilin in dogs. Jpn. J. Pharmacol. 71, 29-38.
65. Itoh, Z., Aizawa, S., Takeuchi, S., and Couch, E. F. (1975). "Hunger contractions and motilin, "in Proceedings of the Fifth International Symposium on Gastrointestinal Motility, ed. G. Vantrappen (Herentals: Typoff Press), 48-55.
66. Jarvie, E. M., North Laidler, V., Corcoran, S., Bassil, A., and Sanger, G. J. (2007). Differences between the abilities of tegaserod and motilin receptor agonists to stimulate gastric motility in vitro. Br. J. Pharmacol. 150, 455-462.
67. Kaiya, H., Miyazato, M., Kangawa, K., Peter, R. E., and Unniappan, S. (2008). Ghrelin: a multifunctional hormone in non-mammalian vertebrates. Comp. Biochem. Physiol., Part A Mol. Integr. Physiol. 149, 109-128.
68. Katayama, Y., Hirai, K., Homma, T., Noda, Y., and Honda, K. (2005). Actions of orexins on individual myenteric neurons of the guinea-pig ileum: orexin A or B? Neuroreport 16, 745-749.
69. Kellow, J. E., Borody, T. J., Phillips, S. F., Tucker, R. L., andHaddad, A. C. (1986). Human interdigestive motility: variations in patterns from esophagus to colon. Gastroenterology 91, 386-395.
70. Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., and Kangawa, K. (1999). Ghrelin is agrowth-hormone-releasing acylated peptide from stomach. Nature 402, 656-660.
71. Komaki, G., Matsumoto, Y., Nishikata, H., Kawai, K., Nozaki, T., Takii, M., Sogawa, H., and Kubo, C. (2001). Orexin-A and leptin change inversely in fasting non-obese subjects. Eur. J. Endocrinol. 144, 645-651.
72. Kumar, R., Salehi, A., Rehfeld, I. E, Hoglund, P., Lindstrom, E., and Hakanson, R. (2010). Proghrelin peptides: desacyl ghrelin is a powerful inhibitor of acylated ghrelin, likely to impair physiological effects of acyl ghrelin but not of obestatin. A study of pancreatic polypeptide secretion from mouse islets. Regul. Pept. 164, 65-70.
73. Labò, G., Bortolotti, M., Vezzadini, P., and Bonora, G. (1990). Interdigestive gastroduodenal motility and serum motilin levels in patients with idi-opathic delay in gastric emptying. Gastroenterology 90, 20-26.
74. Lagaud, G. J., Young, A., Acena, A., Morton, M. F., Barrett, T. D., and Shankley, N. P. (2007). Obestatin reduces food intake and suppresses body weight gain in rodents. Biochem. Biophys. Res. Commun. 357, 264-269.
75. le Roux, C. W., Neary, N. M., Halsey, T. J., Small, C. J., Martinez-Isla, A. M., Ghatei, M. A., Theodorou, N. A., and Bloom, S. R. (2005). Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy. J. Clin. Endocrinol. Metab. 90, 4521-4524.
76. Lear, P. V., Iglesias, M. J., Feijóo-Bandin, S., Rodriguez-Penas, D., Mosquera-Leal, A., Garcia-Rua, V., Gualilo, O., Ghè, C., Arnoletti, E., Muccioli, G., Diéguez, C., Gonzélez-Juanatey, J. R., and Lago, E (2010). Des-acyl ghrelin has specific binding sites and different metabolic effects from ghrelin cardiomyocytes. Endocrinology 151, 3286-3298.
77. Lee, K. Y., Chang, T. M., and Chey, W. Y. (1983). Effect of rabbit antimo-tilin serum on myoelectric activity and plasma motilin concentration in fasting dog. Am. J. Physiol. 245, G547-G553.
78. Leite-Moreira, A. F., and Soares, J. -B. (2007). Physiological, pathophysi-ological and potential therapeutic roles of ghrelin. Drug Discov. Today 12, 276-288.
79. Levin, F., Edholm, T., Schmidt, P. T., Grybäck, P., Jacobsson, H., Degerblad, M., Höybye, C., Holst, J. J., Rehfeld, J. F., Hellström, P. M., and Näslund, E. (2006). Ghrelin stimulates gastric emptying and hunger in normal-weight humans J. Clin. Endocrinol. Metab. 91, 3296-3302.
80. Liu, J., Prudom, C. E., Nass, R., Pezzoli, S. S., Oliveri, M. C., Johnson, M. L., Veldhuis, P., Gordon, D. A., Howard, A. D., Witcher, D. R., Geysen, H. M., Gaylinn, B. D., and Thorner, M. O. (2008). Novel ghrelin assays provide evidence for independent regulation of ghrelin acylation and secretion in healthyyoungmen. J. Clin. Endocrinol. Metab. 93, 1980-1987.
81. Liu, Y. -L., Malik, N., Sanger, G. J., and Andrews, P. L. (2006). Ghrelin alleviates cancer chemotherapy-associated dyspepsia in mice. Cancer Chemother. Pharmacol. 58, 326-333.
82. Matsuura, B., Dong, M., Naik, S., Miller, L. J., and Onji, M. (2006). Differential contributions of motilin receptor extracellular domains for peptide and non-peptidyl agonist binding and activity. J. Biol. Chem. 281, 12390-12396.
83. McCallum, R. W., Cynshi, O., US Investigative Team. (2007). Efficacy of mitemcinal, a motilin agonist, on gastrointestinal symptoms in patients with symptoms suggesting diabetic gas-tropathy: a randomized, multicenter, placebo-controlled trial. Aliment. Pharmacol. Ther. 26, 107-116.
84. Medhus, A. W., Sandstad, O., Naslund, E., Hellstrom, P. M., and Husebye, E. (1999). The influence of the migrating motor complex on the postprandial endocrine response. Scand. J. Gastroenterol. 34, 1012-1018.
85. Mochiki, E., Inui, A., Satoh, M., Mizumoto, A., and Itoh, Z. (1997). Motilin is a biosignal controlling cyclic release of pancreatic polypeptide via the vagus in fasted dogs. Am. J. Physiol. 272, G224-G232.
86. Moechars, D., Depoortere, I., Moreaux, B., de Smet, B., Goris, I., Hoskens, L., Daneels, G., Kass, S., Ver Donck, L., Peeters, T., and Coulie, B. (2006). Altered gastrointestinal and metabolic function in the GPR39 -obestatin receptor knockout mouse. Gastroenterology 131, 1131-1141.
87. Moulin, A., Ryan, J., Martinez, J., and Fehrentz, J. -A. (2007). Recent developments in ghrelin receptor ligands. ChemMedChem 2, 1242-1259.
88. Murphy, K. G., and Bloom, S. R. (2006). Gut peptides and the regulation of energy homeostasis. Nature 444, 854-859.
89. Nagaya, N., Uematsu, M., Kojima, M., Ikeda, Y., Yoshihara, F., Shimizu, W., Hosoda, H., Hirota, Y., Ishida, H., Mori, H., and Kangawa, K. (2001). Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 104, 1430-1435.
90. Nakabayashi, M., Suzuki, T., Takahashi, K., Totsune, K., Muramatsu, Y., Kaneko, C., Date, F., Takeyama, J., Darnel, A. D., Moriya, T., and Sasano, H. (2003). Orexin-A expression in human peripheral tissues. Mol. Cell. Endocrinol. 205, 43-50.
91. Nakai, Y., Hosoda, H., Nin, K., Ooya, C., Hayashi, H., Akamizu, T., and Kangawa, K. (2003). Plasma levels of active form of ghrelin during oral glucose tolerance test in patients with anorexia nervosa. Eur. J. Endocrinol. 149, R1-R3.
92. Nakajima, H., Mochiki, E., Zietlow, A., Ludwig, K., and Takahashi, T. (2010). Mechanism of interdigestive migrating motor complex in conscious dogs. J. Gastroenterol. 45, 506-514.
93. Näslund, E., Backman, L., Theodorsson, E., and Hellström, P. M. (1998). Intraduodenal neuropeptide levels, but not plasma levels, vary in a cyclic fashion with the migrating motor complex. Acta Physiol. Scand. 164, 317-323.
94. Näslund, E., Ehrström, M., Ma, J., Hellström, P. M., and Kirchgessner, A. L. (2002). Localization and effects of orexin on fasting motility in the rat duodenum. Am. J. Physiol. 282, G470-G479.
95. Näslund, E., and Hellström, P. M. (2007). Appetite signaling: from gut peptides and enteric nerves to brain. Physiol. Behav. 92, 256-262.
96. Neary, N. M., Small, C. J., Wren, A. M., Lee, J. L., Druce, M. R., Palmieri, C., Frost, G. S., Ghatei, M. A., Coombes, R. C., and Bloom, S. R. (2004). Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J. Clin. Endocrinol. Metab. 89, 2832-2836.
97. Nguyen, N., Fraser, R. J., Bryant, L., Burgstad, C. M., Chapman, M., Clarke, S., and Holloway, R. H. (2010). Abnormalities in plasma motilin response to small intestinal nutrient stimulation in critically ill patients. Gastroenterology 138(Suppl. 1), S405-S406.
98. Nieuwenhuijs, V. B., Verheem, A., van Duijvenbode-Beumer, H., Visser, M. R., Verhoef, J., Gooszen, H. G., and Akkermans, L. M. (1998). The role of interdigestive small bowel motility in the regulation of gut microflora, bacterial overgrowth, and bacterial transloca-tion in rats. Ann. Surg. 228, 188-193.
99. Nishizawa, T., Suzuki, H., Nomoto, Y., Masaoka, T., Hosoda, H., Mori, M., Ohara, T., Morishita, T., Kangawa, K., andHibi, T. (2006). Enhanced plasma ghrelin levels in patients with functional dyspepsia. Aliment. Pharmacol. Ther. 24(Suppl. 4), 104-110.
100. Nogueiras, R., and Tschöp, M. (2005). Biomedicine. Separation of conjoined hormones yields appetite rivals. Science 310, 985-986.
101. Otto, B., Cuntz, U., Fruehauf, E., Wawarta, R., Folwaczny, C., Riepl, R. L., Heiman, M. L., Lehnert, P., Fichter, M., and Tschöp, M. (2001). Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur. J. Endocrinol. 145, 669-673.
102. Ozaki, K., Onoma, M., Muramatsu, H., Sudo, H., Yoshida, S., Shiokawa, R., Yogo, K., Kamei, K., Cynshi, O., Kuromaru, O., Peeters, T. L., and Takanashi, H. (2009). An orally active motilin receptor antagonist, MA-2029, inhibits motilin-induced gastrointestinal motility, increase in fun dic tone, and diarrhea in conscious dogs without affecting gastric emptying. Eur. J. Pharmacol. 615, 185-192.
103. Page, A. J., Slattery, J. A., Milte, C., Laker, R., O'Donnell, T., Dorian, C., Brierley, S. M., and Blackshaw, L. A. (2007). Ghrelin selectively reduces mechano-sensitivity of upper gastrointestinal vagal afferents. Am. J. Physiol. 292, G1376-G1384.
104. Peeters, T. L. (1993). Erythromycin and other macrolides as prokinetic agents. Gastroenterology 105, 1886-1899.
105. Peeters, T. L., Janssens, J., and Van trappen, G. R. (1983). Somatostatin and the interdigestive migrating motor complex in man. Regul. Pept. 5, 209-217.
106. Popescu, I., Fleshner, P., Pezzullo, J., Charlon, P., Kosutic, G., and Senagore, A. (2009). The ghrelin agonist TZP-101 for management of postoperative ileus after partial colectomy: a randomized, dose-ranging, placebo-controlled clinical trial. Dis. Colon Rectum 53, 126-134.
107. Raun, K., Hansen, B. S., Johansen, N. L., Thogersen, H., Madsen, K., Ankersen, M., and Andersen, P. H. (1998). Ipamorelin, the first selective growth hormone secretagogue. Eur. J. Endocrinol. 139, 552-561.
108. Read, N. W. (1992). Role of gastrointestinal factors in hunger and satiety in man. Proc. Nutr. Soc. 51, 7-11.
109. Rees, W. D. W., Malagelada, J. R., Miller, L. J., and Go, V. L. W. (1982). Human interdigestive and postprandial gastrointestinal motor and gastrointestinal hormone patterns. Dig. Dis. Sci. 27, 321-329.
110. Richards, R. D., Davenport, K., and Mccallum, R. W. (1993). The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. Am. J. Gastroenterol. 88, 203-207.
111. Rolls, E. T. (1981). Central nervous mechanisms related to feeding and appetite. Br. Med. Bull. 37, 131-134.
112. Ruckebusch, Y., Pairet, M., and Becht, J. L. (1985). Origin and characterization of migrating myoelectric complex in rabbits. Dig. Dis. Sci. 30, 742-748.
113. Rudd, J. A., Ngan, M. P., Wai, M. K., King, A. G., Witherington, J., Andrews, P. L. R., and Sanger, G. J. (2006). Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cispla-tin. Neurosci. Lett. 392, 79-83.
114. Sakata, I., Yamazaki, M., Inoue, K., Hayashi, Y., Kangawa, K., and Sakai, T. (2003). Growth hormone secretagogue receptor expression in the cells of the stomach-projected afferent nerve in the rat nodose ganglion. Neurosci. Lett. 342, 183-186.
115. Samson, W. K., White, M. M., Price, C., and Ferguson, A. V. (2007). Obestatin acts in brain to inhibit thirst. Am. J. Physiol. 292, R637-R643.
116. Sanger, G. J. (2008). Motilin, ghrelin and related neuropeptides as targets for the treatment of GI diseases. Drug Discov. Today 13, 234-239.
117. Sanger, G. J., and Alpers, D. (2008). Development of drugsforgas trointesti-nalmotor disorders: translating science to clinical need. Neurogastroenterol. Motil. 20, 177-184.
118. Sanger, G. J., and Lee, K. (2008). Hormones of the gut-brain axis as targets for the treatment of upper GI disorders. Nat. Rev. DrugDiscov. 7, 241-254.
119. Sanger, G. J., Westaway, S. M., Barnes, A. A., MacPherson, D. T., Muir, A. I., Jarvie, E. M., Bolton, V., Cellek, S., Näslund, E., Hellström, P. M., Borman, R. A., Unsworth, W. P., Matthews, K. L., and Lee, K. (2009). GSK962040: a small molecule, selective motilin receptor agonist, effective as a stimulant of human and rabbit gastrointestinal motility. Neurogastroenterol. Motil. 21, 657-666.
120. Sarna, S. K. (1985). Cyclic motor activity; migrating motor complex: 1985. Gastroenterology 89, 894-913.
121. Scott, V., McDade, D. M., and Luckman, S. M. (2007). Rapid changes in the sensitivity of arcuate nucleus neurons to central ghrelin in relation to feeding status. Physiol. Behav. 90, 180-185.
122. Seoane, L. M., Al-Massadi, O., Pazos, Y., Pagotto, U., and Casanueva, E E (2006). Central obestatin administration does not modify either spontaneous or ghrelin-induced food intake in rats. J. Endocrinol. Invest. 29, RC13-RC15.
123. Sharir, H., Zinger, A., Nevo, A., Sekler, I., and Hershfinkel. M. (2010). Zn2 + released from injured cells is acting via the Zn2 + - sensing receptor, ZnR, to trigger signalling leading to epithelial repair. J. Biol. Chem. 285, 26097-26106.
124. Shibata, C., Naito, H., Ueno, T., Jin, X. X.-L., Funayama, Y., Fukushima, K., Matsuno, S., and Sasaki, I. (2002). Intraduodenal capsaicin inhibits gastric migrating motor complex via an extrinsic neural reflex in conscious dogs. Neurogastroenterol. Motil. 14, 543-551.
125. Sibilia, V., Bresciani, E., Lattuada, N., Rapetti, D., Locatelli, V., De Luca, V., Dona, E, Netti, C., Torsello, A., and Guidobono, E (2006). Intracerebroventricular acute and chronic administration of obestatin minimally affect food intake but not weight gain in the rat. J. Endocrinol. Invest. 29, RC31-RC34.
126. Sudo, H., Yoshida, S., Ozaki, K., Muramatsu, H., Onoma, M., Yogo, K., Kamei, K., Cynshi, O., Kuromaru, O., Peeters, T. L., and Takanashi, H. (2008). Oral administration of MA-2029, a novel selective and competitive motilin receptor antagonist, inhibits motilin-induced intestinal contractions and visceral pain in rabbits. Eur. J. Pharmacol. 581, 296-305.
127. Suzuki, H., Mochiki, E., Haga, N., Satoh, M., Mizumoto, A., and Itoh, Z. (1998). Motilin controls cyclic release of insulin through vagal cholinergic mus-carinic pathways in fasted dogs. Am. J. Physiol. 274, G87-G95.
128. Szurszewski, J. H. (1969). A migrating electric complex of the canine small intestine. Am. J. Physiol. 217, 1757-1763.
129. Tack, J., Depoortere, I., Bisschops, R., Delporte, C., Coulie, B., Meulemans, A., and Janssens, J. (2006). Influence of ghrelin on interdigestive gastrointestinal motility in humans. Gut55, 327-333.
130. Takanashi, H., and Cynshi, O. (2009). Motilides: a long and winding road: lessons from mitemcinal (GM-611) on diabetic gastroparesis. Regul. Pept. 155, 18-23.
131. Takahashi, N., Koba, N., Yamamoto, T., andSudo, M. (2010). Characterisation of a novel, potent and selective small molecule motilin receptor agonist, RQ-00201894. Gastroenterology 138(Suppl. 1), S-713.
132. Tanaka, M., Naruo, T., Muranaga, T., Yasuhara, D., Shiiya, T., Nakazato, M., Matsukura, S., andNozoe, S. -I. (2002). Increased fasting plasma ghrelin levels in patients with bulimia nervosa. Eur. J. Endocrinol. 146, R1-R3.
133. Tanaka, T., Kendrick, M. L., Zyromski, N. J., Meile, T., and Sarr, M. G. (2001). Vagal innervations modulates motor pattern but not initiation of canine gastric migrating motor complex. Am. J. Physiol. 281, G283-G292.
134. Thollander, M., Hellström, P. M., Svensson, T. H., and Gazelius, B. (1996). Haemodynamic changes in the small intestine correlate to migrating motor complex in humans. Eur. J. Gastroenterol. Hepatol. 8, 777-785.
135. Thomas, H., Chen, C., and Marsault, E. (2007). The motilin receptor antagonist TZP-201 is highly effective in the control of irinotecan induced diarrhea in beagle dogs. Neurogastroenterol. Motil. 19(Suppl. 3), 35.
136. Tomita, R. (2009). Relationship between interdigestive migrating motor complex and gut hormones in human. Hepatogastroenterology 56, 714-717.
137. Tomita, R., Fujisaki, S., Tanjoh, K., and Fukuzawa, M. (2003). Relationship between jejuna interdigestive migrating motor complex and quality of life after total gastrectomy with Rouxx-en-Y reconstruction for early gastric cancer. World J. Surg. 27, 159-163.
138. Toshinai, K., Yamaguchi, H., Sun, Y., Smith, R. G., Yamanaka, A., Sakurai, T., Date, Y., Mondal, M. S., Shimbara, T., Kawagoe, T., Murakami, N., Miyazato, M., Kangawa, K., and Nakazato, M. (2006). Des-Acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor. Endocrinology 147, 2306-2314.
139. Tremblay, F., Perreault, M., Klaman, L. D., Tobin, J. F., Smith, E., and Gimeno, R. E. (2007). Normal food intake and body weight in mice lacking the G protein-coupled receptor GPR39. Endocrinology 148, 501-506.
140. Tremblay, F., Richard, A. -M. T., Will, S., Syed, J., Stedman, N., Perreault, M., and Gimeno, R. E. (2009). Disruption of G protein-coupled receptor 39 impairs insulin secretion in vivo. Endocrinology 150, 2586-2595.
141. Trudel, L., Bouin, M., Tomasetto, C., Eberling, P., St-Pierre, S., Bannon, P., L'Heureux, M. C., and Poitras, P. (2003). Two new peptides to improve postoperative gastric ileus in dog. Peptides 24, 531-534.
142. Vantrappen, G., Janssens, J., Hellemans, J., and Ghoos, Y. (1977). The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J. Clin. Invest. 59, 1158-1166.
143. Venkova, K., Thomas, H., Fraser, G. L., and Greenwood-Van Meerveld, B. (2009a). Effect of TZP-201, a novel motilin receptor antagonist, in the colon of the musk shrew (Suncus murinus). J. Pharm. Pharmacol. 61, 367-373.
144. Venkova, K., Mann, W., Nelson, R., and Greenwood-Van Meerveld, B. (2009b). Efficacy of ipamorelin, a novel ghrelin mimetic, in arodent model of postoperative ileus. J. Pharmacol. Exp. Ther. 329, 1110-1116.
145. Vestergaard, E. T. Hansen, T. K., Gormsen, L. C., Jakobsen, P., Moller, N., Christiansen, J. S., and Jorgensen, J. O. L. (2007). Constant intravenous ghrelin infusion in healthy young men: clinical pharma-cokinetics and metabolic effects. Am. J. Physiol. 292, E1829-E1836.
146. Von der Ohe, M. R., Camilleri, M., Thomforde, G. M., and Klee, G. G. (1995). Differential effects of octre-otide on human gastrointestinal motor function. Gut 36, 743-748.
147. Westaway, S. M., and Sanger, G. J. (2009). The identification and rationale for drugs which act at the motilin receptor. Prog. Med. Chem. 48, 31-80. (ed. G. Lawton and D. Witty).
148. Wigglesworth, M., Wolfe, L. A., and Wise, A. (2006). Orphan seven transmembrane receptor screening. Ernst. Schering Found Symp. Proc. 2, 105-143.
149. Williams, D. L., and Cummings, D. E. (2005). Regulation of ghrelin in physiologic and pathophysiologic states. J. Nutr. 135, 1320-1325.
150. Wilmer, A., Tack, J., Coremans, G., Janssens, J., Peeters, T., andVantrappen, G. (1993). 5-Hydroxytryptamine 3 receptors are involved in the initiation of gastric phase 3 motor activity. Gastroenterology 105, 773-778.
151. Wo, J., Malik, R., Nowak, T., Snape, W., Hellström, P. M., Shaughnessy, L., Kosutic, G., and McCallum, R. (2010). TZP-101 (ghrelin agonist) effects on daily vomiting due to diabetic gastroparesis (GP): phase 2 subset analysis. Neurogastroenterol. Motil. 22, 13-14.
152. Yamamoto, I., Kimura, N., Arai, T., and Tanaka, M. (2009). cDNA cloning and mRNA expression of boving GPR39. J. Vet. Med. Sci. 71, 641-644.
153. Yang, J., Brown, M. S., Liang, G., Grishin, N. V., and Goldstein, J. L. (2008). Identification of the acyltrans-ferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 132, 387-396.
154. Yoshida, N., Mizumotor, A., Iowanaga, Y., and Itoh, Z. (1991). Effects of 5-hydroxytryptamine 3 receptor antagonists on gastrointestinal motor activity in conscious dogs. J. Phamacol. Exp. Ther. 256, 272-278.
155. Yoshiya, K., Yamamura, T., Ishikawa, Y., Utsunomiya, J., Mori, K., Seino, Y., Imura, H., andYanaihara, N. (1985). The failure of truncal vagotomy to affect motilin release in dogs. J. Surg. Res. 38, 263-266.
156. Zhang, J. V., Klein, C., Ren, P. -G., Kass, S., Donck, L. V., Moechars, D., and Hsueh, A. J. W. (2007). Response to comment on "obestatin, apep tide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. "Science 315, 766.
157. Zhang, J. V., Ren, P. -G., Avsian-Kretchmer, O., Luo, C. -W., Rauch, R., Klein, C., and Hsueh, A. J. W. (2005). Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 310, 996-986.
158. Zhou, S., Chan, E., Lim, L. Y., Boelsterli, U. A., Li, S. C., Wang, J., Zhang, Q., Huang, M., and Xu, A. (2004). Therapeutic drugs that behave as mechanism-based inhibitors of cytochrome P450 3A4. Curr. DrugMetab. 5, 415-442.
159. Zietlow, A. M., Ludwig, K. A., and Takahashi, T. (2010). Association between plasma ghrelin and motilin levels during MMC cycle in conscious dogs. Regul. Pept. 164, 78-82.
160. Zorrilla, E. P., Iwasaki, S., Moss, J. A., Chang, J., Otsuji, J., Inoue, K., Meijer, M. M., and Janda, K. D. (2006). Vaccination against weight gain. Proc. Natl. Acad. Sci. U. S. A. 103, 13226-13231.